MUSTI, Anna Maria
 Distribuzione geografica
Continente #
EU - Europa 2.918
NA - Nord America 1.126
AS - Asia 245
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
OC - Oceania 1
Totale 4.324
Nazione #
RU - Federazione Russa 2.292
US - Stati Uniti d'America 1.100
UA - Ucraina 226
DE - Germania 148
AT - Austria 95
CN - Cina 94
SE - Svezia 93
SG - Singapore 75
TR - Turchia 37
SN - Senegal 30
CA - Canada 26
IN - India 25
FI - Finlandia 16
IT - Italia 16
GB - Regno Unito 8
RO - Romania 7
NL - Olanda 6
CZ - Repubblica Ceca 5
JP - Giappone 4
HK - Hong Kong 3
EU - Europa 2
HR - Croazia 2
KH - Cambogia 2
PL - Polonia 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BR - Brasile 1
ES - Italia 1
IR - Iran 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
PE - Perù 1
Totale 4.324
Città #
Moscow 2.292
Chandler 266
Jacksonville 147
San Mateo 98
Dearborn 77
Boardman 71
Vienna 68
Singapore 58
Ashburn 37
Izmir 35
Lawrence 31
Roxbury 31
Dakar 30
Brooklyn 23
Des Moines 21
Flensburg 21
Shanghai 21
Ottawa 20
Beijing 17
Helsinki 16
New York 16
Los Angeles 12
Cambridge 9
Inglewood 8
Ogden 8
Wilmington 8
Rende 7
Grafing 6
Guangzhou 6
Bangalore 5
Pune 5
Seattle 5
Toronto 5
Waynesboro 5
Bremen 4
Brno 4
Mömbris 4
Tokyo 4
Changsha 3
Jiaxing 3
Wuhan 3
Yiwu 3
Atlanta 2
Biassono 2
Flensburg-mürwik 2
Fuzhou 2
Hangzhou 2
Hong Kong 2
Houston 2
Jinan 2
Lanzhou 2
Leawood 2
Nanchang 2
Phnom Penh 2
San Francisco 2
Almaty 1
Ardabil 1
Baku 1
Chengdu 1
Chennai 1
Dhaka 1
Falkenstein 1
Gießen 1
Groningen 1
Guiyang 1
Hanover 1
Hefei 1
Jinhua 1
Kent 1
Kilburn 1
Lima 1
London 1
Luoyang 1
Melbourne 1
Mumbai 1
Munich 1
Nanning 1
Nardò 1
Norwalk 1
Olomouc 1
Pentone 1
Qingdao 1
Quanzhou 1
Senigallia 1
Shaoxing 1
Shenzhen 1
Taizhou 1
Tirana 1
Vientiane 1
Warsaw 1
Washington 1
Weifang 1
Weitang 1
Woodbridge 1
Wroclaw 1
Wuxi 1
Zagreb 1
Zhengzhou 1
Totale 3.582
Nome #
c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells 2.365
17 beta -Estradiol, Genistein and 4-Hydroxytamoxifen induce proliferative effects in thyroid cancer cells via G protein couplet-receptor GPR30. 113
17beta- estradiol, genistein and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein coupled – receptor GPR30. 92
The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells 91
GPER Mediates Non-Genomic Effects of Estrogen 90
Crosstalk between Notch, HIF-1α and GPER in breast cancer EMT 87
ERK docking sites mediate the differential capacity of c-Jun and JunD to respond to ERK-signaling 86
Channelrhodopsin-1: a light-gated proton channel in green algae 83
G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells 80
Menin promotes S-phase checkpoint and increases the ratio of homology-directed DNA repair 80
A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells 78
V-RAS PKC dedifferentiate thyroid cells by downregulating nuclear cAMP dependent protein kinase A 72
Differential regulation of c-Jun and JunD by ubiquitin-dependent protein degradation 72
Distinct configurations of ERK docking sites mediate the differential capacity of c-Jun and JunD to sense the duration of ERK-signalling 71
The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells 69
GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs) 65
Menin uncouples Elk-1 and junD phosphorylation from MAP kinase activation 62
c-Jun is essential for the induction of Il-1β gene expression in in vitro 62
The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17-beta estradiol and hydroxitamoxifen in endometrial cancer cells 57
Analysis of JunD N-terminal phosphorylation in the menin-JunD complex 56
Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis 55
Ubiquitin in signal transduction and cell transformation 54
The DEXD/H-box RNA helicase RHII/Gu is a co-factor for c-Jun-activated transcription 53
The v-ki-ras oncogene alters cAMP nuclear signaling by regulating the location and the expression of cAMP-dependent protein kinase IIB 53
Thyroid transcription factor 1 phosphorylation is not required for protein kinase A-dependent transcription of the thyroglobulin promoter 51
The G protein-coupled receptor GPR30 mediates the prolifertaive effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. 47
Negative charged threonine 95 of c-Jun is essential for c-Jun N-terminal kinase-dependent phosphorylation of threonine 91/93 and stress-induced c-Jun biological activity 45
Reduced ubiquitin-depebndent degradetion of c-jun after phosphorylation by MAP kinases 42
Multiple members of the mitogen-activated protein kinase family are necessary for PED/PEA-15 anti-apoptotic function 40
Multisite phosphorylation of c-Jun at threonine 91/93/95 triggers the onset of c-Jun pro-apoptotic activity in cerebellar granule neurons 39
The Multifaceted Output of c-Jun Biological Activity: Focus at the Junction of CD8 T Cell Activation and Exhaustion 33
Totale 4.343
Categoria #
all - tutte 15.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.314


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020209 0 0 0 0 15 81 24 35 6 3 32 13
2020/2021298 37 0 30 30 1 35 0 40 56 30 12 27
2021/2022399 1 41 2 44 43 6 1 101 3 7 53 97
2022/2023541 56 84 26 89 57 64 0 55 61 11 9 29
2023/20241.454 45 15 23 5 21 185 376 340 27 158 128 131
2024/20251.265 458 297 296 195 19 0 0 0 0 0 0 0
Totale 4.343